Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Phase IIa crossover study of SLx-2101 in hypertension
2007-001668-62Phase 2Completed
- Sponsor
- Surface Logix, Inc.
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of slx-2101 in hypertension (HTN) (3 arms), sponsored by Surface Logix, Inc. Primary endpoints: Placebo-corrected supine peripheral systolic blood pressure, Placebo-corrected supine peripheral diastolic blood pressure and 2 more. Started Aug 2007; status: completed.
02
Drugs
slx-2101
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2007-001668-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001668-62.